scholarly article | Q13442814 |
P2093 | author name string | Giugliano LG | |
Ribeiro ST | |||
Ulhoa CJ | |||
Vainstein MH | |||
P433 | issue | 1 | |
P921 | main subject | Escherichia coli | Q25419 |
P304 | page(s) | 3-9 | |
P577 | publication date | 1995-01-01 | |
P1433 | published in | Journal of Medical Microbiology | Q15708716 |
P1476 | title | Free secretory component and lactoferrin of human milk inhibit the adhesion of enterotoxigenic Escherichia coli | |
P478 | volume | 42 |
Q95328526 | Active free secretory component and secretory IgA in human milk: do maternal vaccination, allergy, infection, mode of delivery, nutrition and active lifestyle change their concentrations? |
Q37651476 | Adhesion of Diarrheagenic Escherichia coli and Inhibition by Glycocompounds Engaged in the Mucosal Innate Immunity |
Q35548772 | Anti-adhesion therapy of bacterial diseases: prospects and problems |
Q34173786 | Bioactive factors in human milk |
Q34666017 | Bovine lactoferrin decreases cholera-toxin-induced intestinal fluid accumulation in mice by ganglioside interaction |
Q28137745 | Carbohydrate moieties in human secretory component |
Q43806235 | Dietary bovine lactoferrin induces changes in immunity level and disease resistance in Asian catfish Clarias batrachus |
Q37060544 | Effect of lactoferrin on enteric pathogens |
Q45868649 | Expression of full-length bioactive antimicrobial human lactoferrin in potato plants |
Q41959778 | Expression, purification and biochemical characterization of recombinant murine secretory component: a novel tool in mucosal immunology |
Q41581938 | Factors that explain excretion of enteric pathogens by persons without diarrhea |
Q40303575 | Glycans on secretory component participate in innate protection against mucosal pathogens |
Q40444495 | Human Secretory IgM Antibodies Activate Human Complement and Offer Protection at Mucosal Surface |
Q50075579 | Human milk glycoproteins inhibit the adherence of Salmonella typhimurium to HeLa cells |
Q54521589 | Human secretory immunoglobulin A may contribute to biofilm formation in the gut. |
Q21245322 | Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine |
Q24803073 | In vitro adhesion and invasion inhibition of Shigella dysenteriae, Shigella flexneri and Shigella sonnei clinical strains by human milk proteins |
Q36709727 | Induction of secretory immunity and memory at mucosal surfaces |
Q24806554 | Lactoferrin and free secretory component of human milk inhibit the adhesion of enteropathogenic Escherichia coli to HeLa cells |
Q39671919 | Lactoferrin protects rabbits from Shigella flexneri-induced inflammatory enteritis |
Q37843732 | Lactoferrin: an iron-binding antimicrobial protein against Escherichia coli infection. |
Q33828704 | Mannose-containing oligosaccharides of non-specific human secretory immunoglobulin A mediate inhibition of Vibrio cholerae biofilm formation. |
Q34650340 | Mini-review: Lactoferrin: a bioinspired, anti-biofilm therapeutic |
Q35558518 | Mucosal Immune Development in Early Life: Setting the Stage |
Q41682837 | Mucosal immunity in the female genital tract |
Q44990753 | Multiple cleavage sites for polymeric immunoglobulin receptor |
Q36943322 | Polymeric immunoglobulin receptor traffics through two distinct apically targeted pathways in primary lacrimal gland acinar cells. |
Q40950183 | Recombinant expression of polymeric IgA: incorporation of J chain and secretory component of human origin |
Q34508329 | Recombinant immunoglobulin A: powerful tools for fundamental and applied research |
Q54376098 | Reduction of the amount of intestinal secretory IgA in fulminant hepatic failure. |
Q40631760 | Release of Non‐Glycosylated Polymeric Immunoglobulin Receptor Protein |
Q44791782 | Retinoic acid enhances the gene expression of human polymeric immunoglobulin receptor (pIgR) by TNF-alpha |
Q35130615 | Role of secretory antibodies in the defence against infections |
Q99711025 | Secretory IgA N-glycans contribute to the protection against E. coli O55 infection of germ-free piglets |
Q33960542 | Secretory component: a new role in secretory IgA-mediated immune exclusion in vivo |
Q33347255 | Specific antibody activity, glycan heterogeneity and polyreactivity contribute to the protective activity of S-IgA at mucosal surfaces |
Q34459044 | Structures involved in the interaction of Porphyromonas gingivalis fimbriae and human lactoferrin |
Q33784957 | The B-cell system of human mucosae and exocrine glands |
Q41010889 | The human intestinal immune system: basic cellular and humoral mechanisms |
Q38350313 | The human polymeric immunoglobulin receptor binds to Streptococcus pneumoniae via domains 3 and 4. |
Q77910460 | Thiol-disulfide redox buffers maintain a structure of immunoglobulin A that is essential for optimal in vitro binding to secretory component |
Q26997004 | Treatment of microbial biofilms in the post-antibiotic era: prophylactic and therapeutic use of antimicrobial peptides and their design by bioinformatics tools |
Search more.